DrAid™ is certified by the US Food and Drug Administration (FDA)

{ "id": "KeS16WSD-B", "type": "myToolImages", "data": { "data": "" } }

FDA – The “international passport” for DrAid™  

On September 2, 2022, VinBrain's DrAid™ product was officially acknowledged by the FDA as having the highest quality and safety standards. “This is such a deserving result for the endless efforts during the past three years of the VinBrain team,” said Mr. Truong Quoc Hung, CEO of VinBrain, when he received notice from the American "medical gatekeeper".

DrAid™ is the first and only AI product for chest X-ray diagnosis in Vietnam and Southeast Asia that meets FDA standards. Around the world, before Vietnam, there were only five countries, namely the US, Israel, India, South Korea, and Australia, that have businesses making AI products for X-ray diagnostics that have achieved this rigorous FDA certification.

For a long time, FDA certification has been considered the mandatory "passport" for manufacturers, medical equipment distributors, and people wishing to export healthcare-related products in the toughest markets in the world. To meet FDA standards, products must pass a series of rigorous and strict evaluations of quality to ensure their absolute safety when operating in practice. For each field, the number of officials participating in the inspection can be up to more than 1,000 investigators and inspectors and more than 2,000 scientists.

With FDA approval, DrAid™ - a product made by a Vietnamese firm - is legally allowed to do business in the US market. With the "gold guarantee" from the FDA, the made-in-Vietnam "AI assistant" can also expand its business globally.

The crystallization of Vietnamese minds

Researched in 2019, in a short time, DrAid™, the first AI technology product for the healthcare industry developed by a Vietnamese firm, has achieved remarkable achievements. VinBrain's medical imaging software currently owns the largest dataset in Vietnam with 2,263,000 million images, of which 390,000 labeled images have received the consensus of a panel of doctors with over five years of experience.

Experimental results show that DrAid™ helps medical staffs to automatically screen 21 lung, heart, and bone abnormalities based on straight chest X-rays within five seconds with an average accuracy of 91,2%. This solution is also effective in supporting the classification and localization of liver cancer lesions on CT images with an average accuracy of over 95%.

The application is currently being used by nearly 2,000 doctors working in over 100 hospitals across Vietnam, including Hospital 108, Hospital 199, Hospital K, and the University Hospital of Medicine and Pharmacy in Ho Chi Minh City. Up to now, DrAid™ has proven outstanding performance by contributing to saving 80-85% of initial screening time and increasing diagnostic accuracy rates by up to 25%.

DrAid™ is being widely used in major hospitals across the country

{ "id": "0NFyJ6iT9f", "type": "myToolImages", "data": { "data": "" } }

“Natural aromatherapy”, in the context of AI, is believed to be the key to reducing pressure on the medical team, increasing diagnostic accuracy, and providing equal medical opportunities for billions of people. Many large international organizations have also actively sought out DrAid™.

Recently, the WHO authorized FINDDX to run tests on DrAid™ before applied it throughout the world. If it passes the rigorous tests from FINDDX, the WHO shall certify that VinBrain's DrAid™ can work with medical staffs to help billions of worldwide patients, especially in places where according to statistics, up to 10% of patients still die or are seriously injured because of misdiagnosis.

VinBrain strengthens relations with many major international partners in the research and implementation of DrAid™.

{ "id": "4-cchB65tN", "type": "myToolImages", "data": { "data": "" } }

VinBrain strengthens relations with many major international partners in the research and implementation of DrAid™.

At the same time, the leading artificial intelligence marketplace Ferrum has added DrAid™ to its portfolio of AI-based products used for X-rays.

In the coming time, with the "international passport" issued by the FDA, VinBrain is preparing its development plans to reach new heights, including scaling up the AI application solution in the medical field in different target markets, including Southeast Asia, Europe and North America. This is also a meaningful step to affirm Vietnamese innovation and a Vietnamese brand in the international arena.

VinBrain is a leading company providing AI products for Healthcare, invested by Vingroup - the largest private economic group in Vietnam. VinBrain's goal is to solve crucial and challenging problems, connecting the fields of BigData, AI, IoT, and IoP in healthcare activities to improve the quality of healthcare services for patients around the globe.

Learn more about VinBrain at: https://vinbrain.net/